Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bronchiolitis Obliterans Syndrome × Oxycodone × Clear all

Sponsor

Conditions

Neoplasms 6 Cancer Pain 5 Pain 2 Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Malignant Neoplasms of Female Genital Organs 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1

Interventions

tofacitinib 7 Rituximab 3 obinutuzumab 2 nilotinib 2 ibrutinib 2 bosutinib 2 Imatinib Mesylate 2 ruxolitinib 1 ofatumumab 1 fludarabine 1 canakinumab 1 belumosudil 1 baricitinib 1 axatilimab 1 Sofosbuvir 1 Ribavirin 1 Lenalidomide 1 KW-2478 1 KD025 1 Interleukin-15 1 Hsp90 inhibitor KU757 1 Etanercept 1 Dasatinib 1 Cyclophosphamide 1 Bortezomib 1 BMS-833923 1 B3(Fv)-PE38KDEL recombinant immunotoxin 1 Alemtuzumab 1 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡